Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Authors
Keywords
-
Journal
REVISTA BRASILEIRA DE PSIQUIATRIA
Volume -, Issue -, Pages -
Publisher
FapUNIFESP (SciELO)
Online
2018-10-17
DOI
10.1590/1516-4446-2017-0015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
- (2017) Karina Genaro et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”
- (2015) Luiza Reali Nazario et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review
- (2015) Darrell G. Boychuk et al. Journal of Oral & Facial Pain and Headache
- Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis
- (2014) Yahiya Y. Syed et al. DRUGS
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
- (2013) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
- (2012) Giuseppe Esposito et al. PHYTOTHERAPY RESEARCH
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Anxiogenic-like effects of chronic cannabidiol administration in rats
- (2011) Maha M. ElBatsh et al. PSYCHOPHARMACOLOGY
- Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
- (2010) Plinio C. Casarotto et al. BEHAVIOURAL PHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
- (2009) José Inácio Lemos et al. BEHAVIOURAL BRAIN RESEARCH
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More